Market cap of Biora Therapeutics Inc. [BIOR] reaches 40.26M – now what?

Biora Therapeutics Inc. [NASDAQ: BIOR] price plunged by -11.66 percent to reach at -$0.03. The company report on November 29, 2022 that Biora Therapeutics Licenses Preeclampsia Rule-Out Test for Commercial Development.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


Avero Diagnostics to Develop and Commercialize, Enabling Potential Future Revenue for Biora Therapeutics.

A sum of 3272871 shares traded at recent session while its average daily volume was at 1.28M shares. Biora Therapeutics Inc. shares reached a high of $0.2217 and dropped to a low of $0.19 until finishing in the latest session at $0.19.

The one-year BIOR stock forecast points to a potential upside of 96.2. The average equity rating for BIOR stock is currently 1.50, trading closer to a bullish pattern in the stock market.

Guru’s Opinion on Biora Therapeutics Inc. [BIOR]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BIOR shares is $5.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BIOR stock is a recommendation set at 1.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

The Average True Range (ATR) for Biora Therapeutics Inc. is set at 0.03, with the Price to Sales ratio for BIOR stock in the period of the last 12 months amounting to 57.51.

BIOR Stock Performance Analysis:

Biora Therapeutics Inc. [BIOR] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -22.41. With this latest performance, BIOR shares dropped by -34.24% in over the last four-week period, additionally sinking by -75.20% over the last 6 months – not to mention a drop of -93.04% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BIOR stock in for the last two-week period is set at 28.96, with the RSI for the last a single of trading hit 27.17, and the three-weeks RSI is set at 29.85 for Biora Therapeutics Inc. [BIOR]. The present Moving Average for the last 50 days of trading for this stock 0.3448, while it was recorded at 0.2274 for the last single week of trading, and 0.7500 for the last 200 days.

Insight into Biora Therapeutics Inc. Fundamentals:

Operating Margin for any stock indicates how profitable investing would be, and Biora Therapeutics Inc. [BIOR] shares currently have an operating margin of -9449.64 and a Gross Margin at -15.24. Biora Therapeutics Inc.’s Net Margin is presently recorded at -14316.04.

Biora Therapeutics Inc.’s liquidity data is similarly interesting compelling, with a Current Ratio set at 1.70.

Biora Therapeutics Inc. [BIOR] Insider Position Details

There are presently around $9 million, or 24.00% of BIOR stock, in the hands of institutional investors. The top three institutional holders of BIOR stocks are: ATHYRIUM CAPITAL MANAGEMENT, LP with ownership of 29,855,847, which is approximately 0% of the company’s market cap and around 2.20% of the total institutional ownership; NEUBERGER BERMAN GROUP LLC, holding 6,541,060 shares of the stock with an approximate value of $1.24 million in BIOR stocks shares; and VANGUARD GROUP INC, currently with $1.12 million in BIOR stock with ownership of nearly 3.448% of the company’s market capitalization.

Positions in Biora Therapeutics Inc. stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 21 institutional holders increased their position in Biora Therapeutics Inc. [NASDAQ:BIOR] by around 1,149,964 shares. Additionally, 15 investors decreased positions by around 882,642 shares, while 18 investors held positions by with 47,624,740 shares. The mentioned changes placed institutional holdings at 49,657,346 shares, according to the latest SEC report filing. BIOR stock had 7 new institutional investments in for a total of 836,151 shares, while 7 institutional investors sold positions of 159,437 shares during the same period.


Please enter your comment!
Please enter your name here